0001478242-20-000016.txt : 20200220
0001478242-20-000016.hdr.sgml : 20200220
20200220170512
ACCESSION NUMBER: 0001478242-20-000016
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200218
FILED AS OF DATE: 20200220
DATE AS OF CHANGE: 20200220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STAUB W RICHARD
CENTRAL INDEX KEY: 0001181162
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35907
FILM NUMBER: 20636178
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IQVIA HOLDINGS INC.
CENTRAL INDEX KEY: 0001478242
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 271341991
STATE OF INCORPORATION: NC
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4820 EMPEROR BLVD.
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-998-2000
MAIL ADDRESS:
STREET 1: 4820 EMPEROR BLVD.
CITY: DURHAM
STATE: NC
ZIP: 27703
FORMER COMPANY:
FORMER CONFORMED NAME: Quintiles IMS Holdings, Inc.
DATE OF NAME CHANGE: 20161003
FORMER COMPANY:
FORMER CONFORMED NAME: Quintiles Transnational Holdings Inc.
DATE OF NAME CHANGE: 20091208
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-02-18
0001478242
IQVIA HOLDINGS INC.
IQV
0001181162
STAUB W RICHARD
C/O IQVIA HOLDINGS INC.
4820 EMPEROR BLVD.
DURHAM
NC
27703
0
1
0
0
See Remarks
Common Stock
2020-02-18
4
M
0
18224
78.21
A
35953
D
Common Stock
2020-02-18
4
S
0
14550
163.77
D
21403
D
Common Stock
2020-02-18
4
D
0
8674
165.42
D
12729
D
Stock Appreciation Right
78.21
2020-02-18
4
M
0
18224
0
D
2020-02-02
2027-02-02
Common Stock
18224
0
D
The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $162.84 to $164.91 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
President, Research & Development Solutions
/s/ Matthew Gilmartin, Attorney-in-Fact for W. Richard Staub
2020-02-20